Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
focuses on understanding the molecular and cellular mechanisms of systemic amyloid deposition, with particular emphasis on AL and ATTR amyloidosis. We use in situ structural approaches to visualize amyloid
-
About the role: The Costa Laboratory (https://profiles.imperial.ac.uk/t.costa ), in the Department of Life Sciences (https://www.imperial.ac.uk/life-sciences ), Imperial College London, invites
-
Postdoctoral Scholar in Structural Biology & Translational Medicine Are you a structural biologist looking to bridge the gap between fundamental discovery and real-world therapeutic applications
-
We have an exciting research opportunity for a Research Assistant / Associate tojoin our team. The post holder will be based at the Cancer Research UK-Scotland Institute (CRUK-SI) in Glasgow https
-
: Biomedicine and Pharmacology Developmental and Regenerative Biology Genomics, Proteomics and Bioinformatics Metabolism and Physiology Molecular and Cellular Biology Neuroscience Computational Structural Biology
-
Education and Center for Protein Design. Further information on the Department can be found at: https://drug.ku.dk/ We welcome applications from ambitious and talented early-career researchers seeking
-
application instructions), please visit: https://www.mpg.de/en/max-planck-postdoc-program . To submit your application online, please visit: https://postdocprogram.mpg.de The application deadline is April 13
-
results-driven person for a postdoctoral position Structure and function of membrane proteins in native systems in the Johansson laboratory at the Department of Medical Biochemistry and Cell Biology
-
incumbent will be responsible for representing current research topics on the structure, molecular function, and mechanisms of biomacromolecules, incorporating modern biochemical and structural biology
-
About the project We explore how post‑translational modifications (PTMs) reshape the structure, function and aggregation of proteins central to neurodegenerative disease. Using cutting‑edge protein